Research output per year
Research output per year
- 1 - 50 out of 65 results
Search results
-
2025
Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer
Iden, C. R., Mustafa, S. M., Øgaard, N., Henriksen, T., Jensen, S. Ø., Ahlborn, L. B., Egebjerg, K., Baeksgaard, L., Garbyal, R. S., Nedergaard, M. K., Achiam, M. P., Andersen, C. L. & Mau-Sørensen, M., Jan 2025, In: Gastric Cancer. 28, 1, p. 83-95 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
4 Citations (Scopus) -
Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patients
Ladekarl, M., Mørk, M. L., Albertsen, E. S., Nielsen, D., Lassen, U., Mau-Sørensen, M., Nielsen, C. M., Jakobsen, A. & von der Maase, H., 8 May 2025, In: The oncologist. 30, 5, oyaf059.Research output: Contribution to journal › Journal article › Research › peer-review
-
2024
Dose reduced preoperative chemotherapy in older patients with resectable gastroesophageal cancer: A real-world data study
Skjoldbirk, J., Egebjerg, K., Qvortrup, C., Lund, C. M., Bæksgaard, L., Achiam, M. P. & Mau-Sørensen, M., Nov 2024, In: Journal of Geriatric Oncology. 15, 8, 102072.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Implementation of perioperative FLOT compared to ECX/EOX chemotherapy regimens in resectable esophagogastric adenocarcinomas: an analysis of real-world data
Egebjerg, K., Andersen, T. S., Bæksgaard, L., Garbyal, R., Siemsen, M., Achiam, M. & Mau-Sørensen, P. M., 14 May 2024, In: Acta Oncologica. 63, p. 322-329 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
2 Citations (Scopus) -
Postoperative Exercise Training in Patients with Colorectal Liver Metastases A Randomized Controlled Trial
Thomsen, S. N., Krabek, R., Yfanti, C., Sjöberg, S., Sundberg, A., Dalsgaard, D. M., Thomsen, L. M., Aasvang, E. K., Qvortrup, C., Mau-Sørensen, M., Pedersen, B. K., Larsen, P. N., Sillesen, M. H., Schultz, N. A., Christensen, J. F. & Simonsen, C., 11 Nov 2024, (E-pub ahead of print) In: Annals of Surgery. 10.1097/SLA.0000000000006587.Research output: Contribution to journal › Journal article › Research › peer-review
3 Citations (Scopus) -
Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors
Steeghs, N., Gomez-Roca, C., Rohrberg, K. S., Mau-Sørensen, M., Robbrecht, D., Tabernero, J., Ahmed, S., Rodriguez-Ruiz, M. E., Ardeshir, C., Schmid, D., Sleiman, N., Watson, C., Piper-Lepoutre, H., Dejardin, D., Evers, S., Boetsch, C., Charo, J., Teichgräber, V. & Melero, I., 1 Jul 2024, In: Clinical Cancer Research. 30, 13, p. 2693-2701 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
10 Citations (Scopus) -
2023
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumours
Chen, X., Isambert, N., López-López, R., Giovannini, M., Pognan, N., Kapoor, S., Quinlan, M., You, B., Cui, X., Rahmanzadeh, G. & Mau-Sorensen, M., Mar 2023, In: British Journal of Clinical Pharmacology. 89, 3, p. 1046-1055 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy
Borch, A., Bjerregaard, A.-M., Araujo Barbosa de Lima, V., Østrup, O., Yde, C. W., Eklund, A. C., Mau-Sørensen, M., Barra, C., Svane, I. M., Nielsen, F. C., Funt, S. A., Lassen, U. & Hadrup, S. R., 2023, In: Frontiers in genetics. 14, p. 1058605 1058605.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Therapy with pembrolizumab in treatment-naïve patients with nonmetastatic, mismatch repair deficient colorectal cancer
Eefsen, R. L., Larsen, J. S., Klarskov, L. L., Altaf, R., Høgdall, E., Ingeholm, P., Lykke, J., Nielsen, D. L., Pfeiffer, P., Poulsen, L. Ø., Qvortrup, C., Schou, J. V., Mau-Sørensen, M., Østerlind, K. & Jensen, B. V., 15 May 2023, In: International Journal of Cancer. 152, 10, p. 2145-2152 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
7 Citations (Scopus) -
2022
A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma
Lassman, A. B., Wen, P. Y., van den Bent, M. J., Plotkin, S. R., Walenkamp, A. M. E., Green, A. L., Li, K., Walker, C. J., Chang, H., Tamir, S., Henegar, L., Shen, Y., Alvarez, M. J., Califano, A., Landesman, Y., Kauffman, M. G., Shacham, S. & Mau-Sørensen, M., 1 Feb 2022, In: Clinical Cancer Research. 28, 3, p. 452-460 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
43 Citations (Scopus) -
First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours
Robbrecht, D., Jungels, C., Sorensen, M. M., Spanggaard, I., Eskens, F., Fretland, S. Ø., Guren, T. K., Aftimos, P., Liberg, D., Svedman, C., Thorsson, L., Steeghs, N. & Awada, A., Apr 2022, In: British Journal of Cancer. 126, 7, p. 1010-1017 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
16 Citations (Scopus) -
Patients in phase 1 cancer trials: psychological distress and understanding of trial information
Gad, K. T., Lassen, U., Duun-Henriksen, A. K., Dalton, S. O., Mau-Sørensen, M., Bidstrup, P. E., Høeg, B. L., Rohrberg, K. S., Spanggaard, I., von Heymann, A. & Johansen, C., 2022, In: Acta Oncologica. 61, 3, p. 341-348 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
2021
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours
van Bussel, M. T. J., Awada, A., de Jonge, M. J. A., Mau-Sørensen, M., Nielsen, D., Schöffski, P., Verheul, H. M. W., Sarholz, B., Berghoff, K., El Bawab, S., Kuipers, M., Damstrup, L., Diaz-Padilla, I. & Schellens, J. H. M., Feb 2021, In: British Journal of Cancer. 124, 4, p. 728-735 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
80 Citations (Scopus) -
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK + advanced tumors
Hurtado, F. K., de Braud, F., De Castro Carpeño, J., de Miguel Luken, M. J., Wang, D., Scott, J., Lau, Y. Y., McCulloch, T. & Mau-Sorensen, M., Apr 2021, In: Cancer Chemotherapy and Pharmacology. 87, 4, p. 475-486 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
11 Citations (Scopus) -
2020
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer
Smyth, L. M., Piha-Paul, S. A., Won, H. H., Schram, A. M., Saura, C., Loi, S., Lu, J., Shapiro, G. I., Juric, D., Mayer, I. A., Arteaga, C. L., de la Fuente, M. I., Brufksy, A. M., Spanggaard, I., Mau-Sorensen, M., Arnedos, M., Moreno, V., Boni, V., Sohn, J. & Schwartzberg, L. S. & 27 others, , Feb 2020, In: Cancer Discovery. 10, 2, p. 198-213 16 p.Research output: Contribution to journal › Journal article › Research › peer-review
94 Citations (Scopus) -
Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies
Vergote, I. B., Lund, B., Peen, U., Umajuridze, Z., Mau-Sorensen, M., Kranich, A., Van Nieuwenhuysen, E., Haslund, C., Nottrup, T., Han, S. N., Concin, N., Unger, T. J., Chai, Y., Au, N., Rashal, T., Joshi, A., Crochiere, M., Landesman, Y., Shah, J. & Shacham, S. & 2 others, , Feb 2020, In: Gynecologic Oncology. 156, 2, p. 308-314 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
39 Citations (Scopus) -
Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers
Høgdall, D., O'Rourke, C. J., Dehlendorff, C., Larsen, O. F., Jensen, L. H., Johansen, A. Z., Dang, H., Factor, V. M., Grunnet, M., Mau-Sørensen, M., Oliveira, D. V. N. P., Linnemann, D., Boisen, M. K., Wang, X. W., Johansen, J. S. & Andersen, J. B., 1 Nov 2020, In: Clinical Cancer Research. 26, 21, p. 5655-5667 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
21 Citations (Scopus) -
2019
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer
Cejalvo, J.-M., Jacob, W., Fleitas Kanonnikoff, T., Felip, E., Navarro Mendivil, A., Martinez Garcia, M., Taus Garcia, A., Leighl, N., Lassen, U., Mau-Soerensen, M., Adessi, C., Michielin, F., James, I., Ceppi, M., Hasmann, M., Weisser, M. & Cervantes, A., 2019, In: ESMO Open. 4, 4, p. e000532Research output: Contribution to journal › Journal article › Research › peer-review
21 Citations (Scopus) -
A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24
Mirza, M. R., Bergmann, T. K., Mau-Sørensen, M., Christensen, R. D., Åvall-Lundqvist, E., Birrer, M. J., Jørgensen, M., Roed, H., Malander, S., Nielsen, F., Lassen, U., Brøsen, K., Bjørge, L. & Mäenpää, J., Oct 2019, In: Cancer Chemotherapy and Pharmacology. 84, 4, p. 791-798 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
23 Citations (Scopus) -
Application of cell-free DNA for genomic tumor profiling: a feasibility study
Ahlborn, L. B., Rohrberg, K. S., Gabrielaite, M., Tuxen, I. V., Yde, C. W., Spanggaard, I., Santoni-Rugiu, E., Nielsen, F. C., Lassen, U., Mau-Sorensen, M. & Østrup, O., 15 Feb 2019, In: Oncotarget. 10, 14, p. 1388-1398 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
16 Citations (Scopus) -
Copenhagen Prospective Personalized Oncology (CoPPO) - Clinical utility of using molecular profiling to select patients to phase 1 trials
Tuxen, I. V., Rohrberg, K. S., Østrup, O., Ahlborn, L. B., Schmidt, A. Y., Spanggaard, I., Hasselby, J. P., Santoni-Rugiu, E., Yde, C. W., Mau-Soerensen, M., Nielsen, F. C. & Lassen, U., 2019, In: Clinical Cancer Research. 25, 4, p. 1239-1247 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
79 Citations (Scopus) -
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
Bertelsen, B., Tuxen, I. V., Yde, C. W., Gabrielaite, M., Torp, M. H., Kinalis, S., Oestrup, O., Rohrberg, K., Spangaard, I., Santoni-Rugiu, E., Wadt, K., Mau-Sorensen, M., Lassen, U. & Nielsen, F. C., 2019, In: Genome Medicine. 4, 1, p. 13 13.Research output: Contribution to journal › Journal article › Research › peer-review
61 Citations (Scopus) -
Pharmacokinetics and Safety of Olaparib in Patients with Advanced Solid Tumours and Renal Impairment
Rolfo, C., de Vos-Geelen, J., Isambert, N., Molife, L. R., Schellens, J. H. M., De Grève, J., Dirix, L., Grundtvig-Sørensen, P., Jerusalem, G., Leunen, K., Mau-Sørensen, M., Plummer, R., Learoyd, M., Bannister, W., Fielding, A. & Ravaud, A., Sept 2019, In: Clinical Pharmacokinetics. 58, 9, p. 1165-1174 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
22 Citations (Scopus) -
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients
Viller Tuxen, I., Barlebo Ahlborn, L., Mau-Soerensen, M., Staal Rohrberg, K., Cilius Nielsen, F., Oestrup, O., Westmose Yde, C., Richter Vogelius, I. & Lassen, U., Jul 2019, In: British Journal of Cancer. 121, 2, p. 125-130 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
11 Citations (Scopus) -
Socioeconomic Differences in Referral to Phase I Cancer Clinical Trials: A Danish Matched Cancer Case-Control Study
Gad, K. T., Johansen, C., Duun-Henriksen, A. K., Krøyer, A., Olsen, M. H., Lassen, U., Mau-Sørensen, M. & Oksberg Dalton, S., 2019, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 13, p. 1111-1119Research output: Contribution to journal › Journal article › Research › peer-review
11 Citations (Scopus) -
Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial
de Bono, J. S., Concin, N., Hong, D. S., Thistlethwaite, F. C., Machiels, J.-P., Arkenau, H.-T., Plummer, R., Jones, R. H., Nielsen, D., Windfeld, K., Ghatta, S., Slomovitz, B. M., Spicer, J. F., Yachnin, J., Ang, J. E., Mau-Sørensen, P. M., Forster, M. D., Collins, D., Dean, E. & Rangwala, R. A. & 1 others, , Mar 2019, In: Lancet Oncology. 20, 3, p. 383-393 11 p.Research output: Contribution to journal › Journal article › Research › peer-review
175 Citations (Scopus) -
2018
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors
Ahlborn, L. B., Tuxen, I. V., Mouliere, F., Kinalis, S., Schmidt, A. Y., Rohrberg, K. S., Santoni-Rugiu, E., Nielsen, F. C., Lassen, U., Yde, C. W., Oestrup, O. & Mau-Sorensen, M., 24 Aug 2018, In: Oncotarget. 9, 66, p. 32570-32579 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
14 Citations (Scopus) -
Enhanced detection of circulating tumor DNA by fragment size analysis
Mouliere, F., Chandrananda, D., Piskorz, A. M., Moore, E. K., Morris, J., Ahlborn, L. B., Mair, R., Goranova, T., Marass, F., Heider, K., Wan, J. C. M., Supernat, A., Hudecova, I., Gounaris, I., Ros, S., Jimenez-Linan, M., Garcia-Corbacho, J., Patel, K., Østrup, O. & Murphy, S. & 17 others, , 7 Nov 2018, In: Science translational medicine. 10, 466, p. eaat4921Research output: Contribution to journal › Journal article › Research › peer-review
736 Citations (Scopus) -
Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapy
Yakymenko, D., Frandsen, K. B., Christensen, I. J., Norgaard, A., Johansson, P. I., Daugaard, G. & Mau-Sorensen, M., 2018, In: Transfusion medicine (Oxford, England). 28, 3, p. 208-215Research output: Contribution to journal › Journal article › Research › peer-review
12 Citations (Scopus) -
Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom's macroglobulinemia
Chen, C., Siegel, D., Gutierrez, M., Jacoby, M., Hofmeister, C. C., Gabrail, N., Baz, R., Mau-Sorensen, M., Berdeja, J. G., Savona, M., Savoie, L., Trudel, S., Areethamsirikul, N., Unger, T. J., Rashal, T., Hanke, T., Kauffman, M., Shacham, S. & Reece, D., 2018, In: Blood. 131, 8, p. 855-863Research output: Contribution to journal › Journal article › Research › peer-review
117 Citations (Scopus) -
2017
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia
Garzon, R., Savona, M., Baz, R., Andreeff, M., Gabrail, N., Gutierrez, M., Savoie, L., Mau-Sorensen, P. M., Wagner-Johnston, N., Yee, K., Unger, T. J., Saint-Martin, J.-R., Carlson, R., Rashal, T., Kashyap, T., Klebanov, B., Shacham, S., Kauffman, M. & Stone, R., 15 Jun 2017, In: Blood. 129, 24, p. 3165-3174 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
124 Citations (Scopus) -
Clopidogrel-Paclitaxel Drug-Drug Interaction: A Pharmacoepidemiologic Study
Agergaard, K., Mau-Sørensen, M., Stage, T. B., Jørgensen, T. L., Hassel, R. E., Steffensen, K. D., Pedersen, J. W., Milo, M., Poulsen, S. H., Pottegård, A., Hallas, J., Brøsen, K. & Bergmann, T. K., Sept 2017, In: Clinical Pharmacology and Therapeutics. 102, 3, p. 547-553 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
29 Citations (Scopus) -
Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols
Ahlborn, L. B., Madsen, M., Jonson, L., Nielsen, F. C., Lassen, U., Yde, C. W. & Mau-Sorensen, M., 1 Oct 2017, In: Clinical Laboratory. 63, 10, p. 1755-1759 5 p.Research output: Contribution to journal › Journal article › Research › peer-review
8 Citations (Scopus) -
Detection of copy number alterations in cell-free tumor DNA from plasma
Østrup, O., Ahlborn, L. B., Lassen, U., Mau-Sørensen, M. & Nielsen, F. C., Jun 2017, In: BBA Clinical. 7, p. 120-126 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
9 Citations (Scopus) -
Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer
Chen, Y., Camacho, S. C., Silvers, T. R., Razak, A. R. A., Gabrail, N. Y., Gerecitano, J. F., Kalir, E., Pereira, E., Evans, B. R., Ramus, S. J., Huang, F., Priedigkeit, N., Rodriguez, E., Donovan, M., Khan, F., Kalir, T., Sebra, R., Uzilov, A., Chen, R. & Sinha, R. & 11 others, , 15 Mar 2017, In: Clinical Cancer Research. 23, 6, p. 1552-1563 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
67 Citations (Scopus) -
Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity
Meulendijks, D., Jacob, W., Voest, E. E., Mau-Sorensen, M., Martinez-Garcia, M., Taus, A., Fleitas Kanonnikoff, T., Cervantes, A., Lolkema, M. P., Langenberg, M. H. G., de Jonge, M. J. A., Sleijfer, S., Han, J.-Y., Calles, A., Felip, E., Kim, S.-W., Schellens, J. H. M., Wilson, S., Thomas, M. & Ceppi, M. & 11 others, , 15 Sept 2017, In: Clinical Cancer Research. 23, 18, p. 5406-5415 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
34 Citations (Scopus) -
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma
Kuruvilla, J., Savona, M., Baz, R., Mau-Sorensen, P. M., Gabrail, N., Garzon, R., Stone, R., Wang, M., Savoie, L., Martin, P., Flinn, I., Jacoby, M., Unger, T. J., Saint-Martin, J.-R., Rashal, T., Friedlander, S., Carlson, R., Kauffman, M., Shacham, S. & Gutierrez, M., 15 Jun 2017, In: Blood. 129, 24, p. 3175-3183 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
130 Citations (Scopus) -
Three-year follow-up of implementation of evidence-based transfusion practice in a tertiary hospital
Nørgaard, A., Stensballe, J., de Lichtenberg, T. H., White, J. O., Perner, A., Wanscher, M., Hillingsø, J., Holm, M. L., Mau-Sørensen, M., Sillesen, H., Kjeldsen, L., Bäck, C., Nielsen, J., Seeberg, J., Hansen, M. B. & Johansson, P. I., 20 Feb 2017, In: Vox Sanguinis. 112, 3, p. 229-239Research output: Contribution to journal › Journal article › Research › peer-review
9 Citations (Scopus) -
2016
Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 - a retrospective case series
Alanin, M. C., Klausen, C., Caye-Thomasen, P., Thomsen, C., Fugleholm, K., Poulsgaard, L., Lassen, U., Mau-Sørensen, P. M. & Hofland, K. F., 2016, In: International Journal of Neuroscience. 126, 11, p. 1002-6Research output: Contribution to journal › Journal article › Research › peer-review
25 Citations (Scopus) -
Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies
Dirix, L., Swaisland, H., Verheul, H. M. W., Rottey, S., Leunen, K., Jerusalem, G., Rolfo, C., Nielsen, D., Molife, L. R., Kristeleit, R., Vos-Geelen, J. D., Mau-Sørensen, M., Soetekouw, P., van Herpen, C., Fielding, A., So, K., Bannister, W. & Plummer, R., Oct 2016, In: Clinical Therapeutics. 38, 10, p. 2286-2299 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
47 Citations (Scopus) -
Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors
Meulendijks, D., Lassen, U. N., Siu, L. L., Huitema, A. D. R., Karanikas, V., Mau-Sorensen, M., Jonker, D. J., Hansen, A. R., Simcox, M. E., Schostack, K. J., Bottino, D., Zhong, H., Roessler, M., Vega-Harring, S. M., Jarutat, T., Geho, D., Wang, K., DeMario, M., Goss, G. D. & Schellens, J. H. M., 2016, In: Clinical Cancer Research. 22, p. 858Research output: Contribution to journal › Journal article › Research › peer-review
17 Citations (Scopus) -
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors
Abdul Razak, A. R., Mau-Soerensen, M., Gabrail, N. Y., Gerecitano, J. F., Shields, A. F., Unger, T. J., Saint-Martin, J. R., Carlson, R., Landesman, Y., McCauley, D., Rashal, T., Lassen, U., Kim, R., Stayner, L.-A., Mirza, M. R., Kauffman, M., Shacham, S. & Mahipal, A., Dec 2016, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34, 34, p. 4142-4150 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
207 Citations (Scopus) -
First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid Tumors
Meulendijks, D., Jacob, W., Martinez-Garcia, M., Taus, A., Lolkema, M. P., Voest, E. E., Langenberg, M. H. G., Fleitas Kanonnikoff, T., Cervantes, A., De Jonge, M. J., Sleijfer, S., Mau-Sørensen, M., Thomas, M., Ceppi, M., Meneses-Lorente, G., James, I., Adessi, C., Michielin, F., Abiraj, K. & Bossenmaier, B. & 3 others, , 2016, In: Clinical Cancer Research. 22, p. 877-85Research output: Contribution to journal › Journal article › Research › peer-review
59 Citations (Scopus) -
2015
A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma
Hansson, M., Gimsing, P., Badros, A., Niskanen, T. M., Nahi, H., Offner, F., Salomo, M., Sonesson, E., Mau-Sørensen, M., Stenberg, Y., Sundberg, A., Teige, I., Van Droogenbroeck, J., Wichert, S., Zangari, M., Frendeus, B., Korsgren, M., Poelman, M. & Tricot, G., 15 Jun 2015, In: Clinical Cancer Research. 21, 12, p. 2730-6 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
45 Citations (Scopus) -
A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers
Lassen, U. N., Meulendijks, D., Siu, L. L., Karanikas, V., Mau-Sorensen, M., Schellens, J. H. M., Jonker, D. J., Hansen, A. R., Simcox, M. E., Schostack, K. J., Bottino, D., Zhong, H., Roessler, M., Vega-Harring, S. M., Jarutat, T., Geho, D., Wang, K., DeMario, M. & Goss, G. D., 15 Jan 2015, In: Clinical Cancer Research. 21, 2, p. 258-66 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
33 Citations (Scopus) -
A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3
Mau-Sørensen, M., Dittrich, C., Dienstmann, R., Lassen, U., Büchler, W., Martinius, H. & Tabernero, J., May 2015, In: Cancer Chemotherapy and Pharmacology. 75, 5, p. 1065-73 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
57 Citations (Scopus) -
Decline in CA19-9 during chemotherapy predicts survival in four independent cohorts of patients with inoperable bile duct cancer
Grunnet, M., Christensen, I. J., Lassen, U., Jensen, L. H., Lydolph, M., Knox, J. J., McNamara, M. G., Jitlal, M., Wasan, H., Bridgewater, J., Valle, J. W. & Mau-Sorensen, M., Jul 2015, In: European journal of cancer (Oxford, England : 1990). 51, 11, p. 1381-8 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
27 Citations (Scopus) -
Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours
Plummer, R., Swaisland, H., Leunen, K., van Herpen, C. M. L., Jerusalem, G., De Grève, J., Lolkema, M. P., Soetekouw, P., Sørensen, M., Nielsen, D., Spicer, J., Fielding, A., So, K., Bannister, W. & Molife, L. R., 2015, In: Cancer Chemotherapy and Pharmacology. 76, 4, p. 723-9 7 p.Research output: Contribution to journal › Journal article › Research › peer-review
50 Citations (Scopus) -
Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma
Lassen, U., Chinot, O. L., McBain, C., Mau-Sørensen, M., Larsen, V. A., Barrie, M., Roth, P., Krieter, O., Wang, K., Habben, K., Tessier, J., Lahr, A. & Weller, M., Jul 2015, In: Neuro-Oncology. 17, 7, p. 1007-15 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
35 Citations (Scopus) -
The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2
Alanin, M. C., Klausen, C., Caye-Thomasen, P., Thomsen, C., Fugleholm, K., Poulsgaard, L., Lassen, U., Sørensen, M. & Hofland, K. F., 2015, In: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery. 272, 12, p. 3627-33Research output: Contribution to journal › Journal article › Research › peer-review
50 Citations (Scopus)